Patents by Inventor Emanuela Gussoni

Emanuela Gussoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS
    Publication number: 20220119489
    Abstract: The present invention features compositions and methods featuring CD82 for treating muscular dystrophies and related disorders. In one aspect, the invention provides a method of preserving or increasing muscle function in a dystrophic cell, the method involving contacting the cell with a CD82 polypeptide or a polynucleotide encoding a CD82 polypeptide.
    Type: Application
    Filed: November 25, 2019
    Publication date: April 21, 2022
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventor: Emanuela GUSSONI
  • Muscle-derived stem cells and uses therefor
    Publication number: 20030003085
    Abstract: A method for purifying muscle stem cells from a myoblast sample isolated from mammalian skeletal muscle is disclosed. Purified muscle stem cells can be used for a variety of purposes, including for systemic delivery of muscle proteins and other desired nucleic acid products to a mammal, for gene therapy, in the treatment muscle diseases, including muscular dystrophies, in the treatment or prophylaxis of inherited or acquired diseases, including genetic diseases and cancer, and in transplanting bone marrow to a mammal.
    Type: Application
    Filed: March 13, 2002
    Publication date: January 2, 2003
    Applicant: The Children's Medical Center Corporation
    Inventors: Louis M. Kunkel, Emanuela Gussoni, Richard C. Mulligan, Yuko Soneoka
  • Methods for treating muscular dystrophy
    Publication number: 20020182192
    Abstract: Methods for treating muscle diseases via bone marrow transplantation of either allogeneic cells or autologous cells engineered to express dystrophin or other gene products affected in muscle diseases are disclosed. Bone marrow cells and bone marrow SP cells (a highly purified population of hematopoietic stem cells) can be used in the methods. Muscle diseases include muscular dystrophies, such as Duchenne muscular dystrophy, Becker muscular dystrophy and limb-girdle muscular dystrophies.
    Type: Application
    Filed: March 14, 2002
    Publication date: December 5, 2002
    Applicant: The Children's Medical Center Corporation
    Inventors: Louis M. Kunkel, Emanuela Gussoni, Richard C. Mulligan, Yuko Soneoka